Table 2.
Side effects after the first and second dose of the Pfizer-BioNTech COVID-19 vaccine.
| Side Effects | Patients n = 44 |
Controls n = 44 |
p Value |
|---|---|---|---|
| After the second dose | |||
| Injection site pain | 20 (45.4%) | 19 (43.2%) | 0.83 |
| Asthenia | 15 (34%) | 14 (31.8%) | 0.82 |
| Musculoskeletal pain | 10 (22.7%) | 11 (25%) | 0.80 |
| Headache | 4 (9%) | 3 (6.8%) | 0.69 |
| Nausea/vomit | 1 (2.2%) | 0 | 0.50 |
| Fever | 2 (4.4%) | 2 (4.4%) | 1 |
| Chills | 2 (4.4%) | 2 (4.4%) | 1 |
| After the first dose | |||
| Injection site pain | 22 (50%) | 20 (45.4%) | 0.67 |
| Asthenia | 12 (27.3%) | 10 (22.7%) | 0.62 |
| Musculoskeletal pain | 8 (18.2%) | 10 (22.7%) | 0.60 |
| Nausea/vomit | 5 (11.4%) | 3 (6.8%) | 0.46 |
| Fever | 3 (6.8%) | 3 (6.8%) | 1 |
| Chills | 0 | 1 (2.2%) | 0.50 |